Eagle's Eye View: Your Weekly CV Update From ACC.org

This week, the discussion dives into how chronic marijuana use impairs endothelial function. The hosts compare the bleeding risks and effectiveness of aspirin versus clopidogrel in treating acute coronary syndromes. Additionally, they highlight the often-overlooked mental health challenges faced by survivors of sudden cardiac arrest, particularly those dealing with the aftermath of ICD shocks. The need for comprehensive mental health support in these cases is emphasized.

This week, the discussion focuses on the CATHEDRAL-HF Trial, highlighting carvedilol's role in treating heart failure with improved ejection fraction. The impact of modifiable lifestyle factors on reducing cardiac conduction disease risk is also examined. Lastly, there's a comparison of amiloride and spironolactone for resistant hypertension, showcasing that both drugs lower systolic pressure, but amiloride may be better tolerated by certain patients. Tune in for insights on enhancing cardiac health!

Delve into the fascinating role of colchicine in reducing serious cardiovascular events, like heart attacks, in patients with vascular disease. Discover the latest findings comparing direct oral anticoagulants to warfarin for those recovering from TAVR procedures. Finally, explore the advantages of conduction system pacing over traditional biventricular pacing for improving heart function and echocardiographic responses. Tune in for these invaluable insights into cardiovascular care!

Discover the intriguing results of the ORBITA-2 Trial and its implications for stress echocardiography before PCI. Delve into why some patients struggle to achieve blood pressure control despite escalating their medication. Finally, learn about the promising strategies for rapid initiation and titration of guideline-recommended therapies in those grappling with heart failure and reduced ejection fraction. Each topic sheds light on evolving practices and their impact on patient care.

Delve into the intriguing relationship between Lp(a) levels and cardiovascular risk. Uncover how high-sensitivity C-reactive protein can identify high-risk plaques after NSTEMI. Explore the battle between pulsed field ablation and cryoablation in treating paroxysmal AFib. Each topic reveals cutting-edge insights in cardiovascular health, backed by extensive research and clinical trials.

Discover how weight management during pregnancy can impact cardiovascular disease risk. Learn about the promising effects of adding ezetimibe to statin therapy post-myocardial infarction. Explore the five-year results of the pivotal PARTNER-3 study, comparing outcomes between transcatheter and surgical aortic valve replacements. These insights reveal crucial connections between pregnancy, heart health, and innovative treatment strategies.

Discover how pre-ablation transesophageal echocardiograms influence patient outcomes. Delve into groundbreaking research comparing TAVI and SAVR in women with severe aortic stenosis, revealing TAVI's potential superiority. Uncover insights from the OCEANIC-AF study, which sheds light on the differing effects of oral anti-coagulants on patient outcomes. These pivotal findings could reshape future cardiovascular treatment approaches.

Dive into groundbreaking cardiovascular research from the recent conference in Chicago. Discover how TAVR compares to surgical aortic valve replacement with impressive five-year results. Learn about the advantages of clopidogrel over aspirin after a PCI and how dapagliflozin benefits older heart failure patients during valve procedures. Plus, see how semaglutide enhances outcomes for peripheral artery disease. Rivaroxaban shines in post-MI settings, alongside innovative dosing strategies for anticoagulants in active cancer patients.

In this week’s View, Dr. Eagle looks at the latest clinical guidance on the management of cardiogenic shock. He then discusses trends in mortality after mitral repair and TAVR. Finally, Dr. Eagle offers a brief exploration into how direct-to-physician industry marketing affects rates of guideline-directed medical therapy (GDMT) surrounding heart failure patients.    Subscribe to Eagle’s Eye View  

In this week’s View, Dr. Eagle examines the dose-response relationship between smoking and subclinical cardiovascular disease markers. He then discusses how the effect of poor sleep increases diabetes risk in women who have had gestational diabetes. Finally, Dr. Eagle offers a look into imaging post-transcatheter aortic valve replacement (TAVR) in patients who may have valve failure.    Subscribe to Eagle’s Eye View